A multicentre randomised controlled trial of the use of continuous positive airway pressure and non-invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO Trial
Gray AJ, Goodacre S, Newby DE, Masson MA, Sampson F, Dixon S, Crane S, Elliott M, Nicholl J
 
 
Record Status

This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.

Citation
Gray AJ, Goodacre S, Newby DE, Masson MA, Sampson F, Dixon S, Crane S, Elliott M, Nicholl J. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non-invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO Trial. Health Technology Assessment 2009; 13(33): 1-106
Authors' objectives

To determine whether non-invasive ventilation reduces mortality and whether there are important differences in outcome by treatment modality.

Authors' conclusions

Study found that non-invasive ventilatory support delivered by either continuous positive airway pressure or non-invasive positive pressure ventilation safely provides earlier improvement and resolution of breathlessness, respiratory distress and metabolic abnormality in patients with severe acute cardiogenic pulmonary oedema

Project page URL
http://www.hta.ac.uk/1338
INAHTA brief and checklist

http://www.inahta.org/Publications/Briefs-Checklist-Impact/2009/4250/

Indexing Status
Subject indexing assigned by NLM
MeSH
Acute Disease; Aged; Aged, 80 and over; Continuous Positive Airway Pressure /economics /standards; Cost-Benefit Analysis; Emergency Service, Hospital; Great Britain /epidemiology; Heart Diseases /complicationss; Intubation, Intratracheal; Male; Middle Aged; Myocardial Infarction /complications; Oxygen Inhalation Therapy; Positive-Pressure Respiration /economics /standards; Pulmonary Edema /etiology /mortality /therapy; Quality-Adjusted Life Years; Survival Analysis
Language Published
English
Country of organisation
England
Address for correspondence
NETSCC, Health Technology Assessment, Alpha House, University of Southampton Science Park, Southampton, SO16 7NS UK Tel: +44 23 8059 5586 Email: hta@hta.ac.uk
AccessionNumber
32005001007
Date bibliographic record published
20/08/2005
Date abstract record published
20/08/2005
 
Health Technology Assessment (HTA) database
Copyright © 2009 Queen's Printer and Controller of HMSO
 
Homepage
Options
Print
PDF
 
PubMed record
Original research
 
Share
 

Message for HTA database users